Topic
zydus therapeutics
1 market across Kalshi and Polymarket.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
 FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)EconomicsEnds Dec 31, 2026 | 77% | — |  80¢ | — |
Topic
1 market across Kalshi and Polymarket.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
| FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)EconomicsEnds Dec 31, 2026 | 77% | — | 80¢ | — |